David C. Benedicto is Chief Financial Officer of Adamis Pharmaceuticals Corp. Currently has a direct ownership of 39,875 shares of ADMP, which is worth approximately $19,538. The most recent transaction as insider was on Mar 18, 2022, when has been sold 3,603 shares (Common Stock) at a price of $0.61 per share, resulting in proceeds of $2,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.9K
0% 3M change
0% 12M change
Total Value Held $19,538

David C. Benedicto Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2022
SELL
Open market or private sale
$2,198 $0.61 p/Share
3,603 Reduced 8.29%
39,875 Common Stock
Dec 01 2021
SELL
Open market or private sale
$10,572 $0.78 p/Share
13,554 Reduced 23.77%
43,478 Common Stock
DCB

David C. Benedicto

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on ADMP

Follow Adamis Pharmaceuticals Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMP shares.

Notify only if

Insider Trading

Get notified when an Adamis Pharmaceuticals Corp insider buys or sells ADMP shares.

Notify only if

News

Receive news related to Adamis Pharmaceuticals Corp

Track Activities on ADMP